To investigate whether ISO offers retinal protection against stroke-induced retinal injury in diabetes, we administered ISO prior to middle cerebral artery occlusion (MCAO) in diabetic mice and studied the role of NLRP3 inflammasome activation in the retina. The gene discussed is NLRP3; the disease is diabetes mellitus.